Clinical Trial Update: Safety and Efficacy of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus. [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the safety and efficacy of inhaled human insulin powder in patients with Type 1 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Human insulin inhalation powder (insulin inhalation powder)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus, Type 1 | Phase 2 | Status: COMPLETED